Tower Research Capital (TRC)’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.4K Sell
1,224
-1,076
-47% -$18.8K ﹤0.01% 3499
2025
Q4
$40.8K Buy
2,300
+1,232
+115% +$21.6K ﹤0.01% 2582
2025
Q3
$19.8K Sell
1,068
-600
-36% -$12.4K ﹤0.01% 3321
2025
Q2
$35.8K Buy
1,668
+1,137
+214% +$24.6K ﹤0.01% 3257
2025
Q1
$13.1K Sell
531
-1,322
-71% -$32.6K ﹤0.01% 3399
2024
Q4
$43K Buy
1,853
+195
+12% +$4.88K ﹤0.01% 2649
2024
Q3
$44.9K Sell
1,658
-2,216
-57% -$67.1K ﹤0.01% 2781
2024
Q2
$111K Buy
3,874
+3,841
+11,639% +$118K ﹤0.01% 2505
2024
Q1
$962 Sell
33
-4,408
-99% -$123K ﹤0.01% 5358
2023
Q4
$144K Buy
4,441
+3,475
+360% +$101K ﹤0.01% 2351
2023
Q3
$30.9K Buy
966
+165
+21% +$6.36K ﹤0.01% 2997
2023
Q2
$35.1K Buy
801
+12
+2% +$553 ﹤0.01% 2884
2023
Q1
$35K Sell
789
-100
-11% -$4.42K ﹤0.01% 2839
2022
Q4
$35K Sell
889
-76
-8% -$3.17K ﹤0.01% 2611
2022
Q3
$44K Buy
965
+68
+8% +$3.33K ﹤0.01% 3285
2022
Q2
$39K Buy
897
+747
+498% +$34.2K ﹤0.01% 3120
2022
Q1
$8K Sell
150
-96
-39% -$4.9K ﹤0.01% 4592
2021
Q4
$15K Sell
246
-288
-54% -$17.9K ﹤0.01% 3996
2021
Q3
$35K Sell
534
-397
-43% -$25.8K ﹤0.01% 3239
2021
Q2
$59K Buy
931
+329
+55% +$18.9K ﹤0.01% 2890
2021
Q1
$29K Sell
602
-8,839
-94% -$424K ﹤0.01% 3585
2020
Q4
$389K Sell
9,441
-2,684
-22% -$123K 0.01% 1188
2020
Q3
$557K Buy
12,125
+10,132
+508% +$470K 0.01% 1564
2020
Q2
$87K Buy
+1,993
New +$89.6K ﹤0.01% 2588
2020
Q1
Sell
-154
Closed -$7K 3493
2019
Q4
$7K Buy
154
+34
+28% +$1.32K ﹤0.01% 2525
2019
Q3
$4K Buy
+120
New +$4.16K ﹤0.01% 3422
2018
Q3
Sell
-140
Closed -$4K 4015
2018
Q2
$4K Sell
140
-3,052
-96% -$65.1K ﹤0.01% 3138
2018
Q1
$48K Sell
3,192
-8,095
-72% -$143K ﹤0.01% 1698
2017
Q4
$217K Buy
+11,287
New +$216K 0.03% 534

Other funds holding KIDS

Tower Research Capital (TRC)'s KIDS Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its OrthoPediatrics (KIDS) stake by 47% in Q1 2026, selling an estimated $18.8K and leaving 1,224 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3499.

Tower Research Capital (TRC) first reported a position in KIDS in Q4 2017 and has held it in 29 quarters since. The position peaked at $557K in Q3 2020. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Tower Research Capital (TRC) held 1,224 shares of OrthoPediatrics worth $19.4K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,076 OrthoPediatrics shares in Q1 2026, an estimated $18.8K.
  • OrthoPediatrics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3499 holding.
  • Tower Research Capital (TRC) first reported a position in OrthoPediatrics in Q4 2017 and has held it in 29 quarters since.
  • Tower Research Capital (TRC)'s OrthoPediatrics position peaked at $557K in Q3 2020.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.